Monday - April 06, 2026

Miglustat Sales Forecast 2034: Miglustat Market Set for Strong Growth Across Rare Lysosomal Disorders, Says DelveInsight

Miglustat Sales The global miglustat market is witnessing steady expansion and is projected to grow significantly through 2034, driven by increasing adoption, expanding patient populations, and rising awareness of rare metabolic disorders. According to DelveInsight’s latest report, “Miglustat Sales Forecast, … Continue reading

Allergic Conjunctivitis Clinical Trials Landscape 2026: Regulatory Approvals (FDA, EMA, PMDA), Drug Innovations, Mechanisms, Routes of Administration, IND/NDA Progress, and Companies | DelveInsight

Allergic Conjunctivitis Clinical Trials Allergic Conjunctivitis companies actively involved in the developing treatment include Aldeyra Therapeutics, Alcon, Novartis AG, Eyevance Pharmaceuticals LLC, Sun Pharmaceutical, Allergan, AbbVie Inc., Santen Pharmaceutical Co., Bausch & Lomb Incorporated, Ocular Therapeutix, Inc., and others. “Allergic … Continue reading

Prader-Willi Syndrome Market Size in the 7MM was ~USD 600 million in 2023 and expected to grow by 2034, reveals DelveInsight

Prader-Willi Syndrome Market Key Prader-Willi Syndrome Companies are Novo Nordisk, Pfizer, Sandoz, Harmony Biosciences, Soleno Therapeutics, Harmony Biosciences, ACADIA Pharmaceuticals, Aardvark Therapeutics, Gedeon Richter, Palobiofarma, ConSynance Therapeutics, and others DelveInsight’s “Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers … Continue reading

Opioid Use Disorder Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Opioid Use Disorder Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Opioid Use Disorder pipeline landscape. It covers the Opioid Use Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Knee Osteoarthritis Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Knee Osteoarthritis Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in the Knee Osteoarthritis pipeline landscape. It covers the Knee Osteoarthritis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading